You have to compare the MC $ 540 for INO and only $ 80 for AVEO and not PPS .
AVEO current PPS should be at least $ 3 with their pipeline and deal with Novartis.
With the current deal with Norvatis PPS should be at least in the $3 i believe they had 15 days to announce the details of the deal we could see news in the next few days.
It's way undervalued at the current PPS ,short term $3 is doable ( 1-2 months) and $7-10 in 12-18 months then again with such a low float anything is possible.IMO
I ve seen many bio stocks with MC trading way more than AVEO #$%$ pipeline .GL
I'm holding for double digits $$$.
I added another 25K shares at 1.22 AVEO has nothing to do with CHINA.Buy when there's blood on the street.
Bottom has been set around 1.30+.Do not panic and sell it here.The high flying stocks will get crush not AVEO.IMO
All small BIO stocks are speculated ,we just need to roll the dices.GL
It's time to crush the short.News could hit the wire on any given time.IMO
Do your own DD .....It's a solid company ..please do your own DD.
AVEO Oncology Announces Presentation of AV-380 Preclinical Data in Cancer Associated Cachexia at 2015 Annual Meeting of the American Association of Cancer Research
CAMBRIDGE, Mass. – April 20, 2015 – AVEO Oncology (NASDAQ:AVEO) today announced the presentation of results from a preclinical study of AV-380, the Company’s potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), in a cachectic human tumor xenograft model with significantly increased plasma GDF15 levels. The data were presented in a poster titled “Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody” at the 2015 Annual Meeting of the American Association of Cancer Research in Philadelphia from April 18-22.
One of the most lethal and debilitating effects of cancer is the development of cachexia. It affects the majority of advanced cancer patients and is thought to be responsible for approximately 30% of all cancer deaths. Cachexia is a complex metabolic syndrome associated with malnutrition and severe involuntary weight loss due to the loss of muscle and fat tissue, as well as the clinical manifestation of anemia, inflammation and suppression of immune functions. Current evidence suggests that a pro-inflammatory state may be responsible for many of the symptoms associated with cachexia. GDF15 is a pro-inflammatory cytokine whose elevated circulating levels are significantly correlated with cachexia in cachectic cancer patients and several animal models of...
It will be up at least 100% from here short term (1 to 2 months).
Check it out .Cash is half of market cap.
without driving this baby way up with such low volume trading. The flippers are the only left selling their small positions.IMO
The selling on low volume was nothing more than short term traders were getting out because of the hype.Volume would be in the 7-10 M shares if the tutes were selling .imo
I'm betting Neuvax will work .The risk -100% vs reward +1000% plus is excellent for us at the current stage.imo
Folks are selling based on this Q earnings? are u kidding me? If everything was up and up do you really think you can buy in this cheap company with MC only at $200+ M with whats in their pipe line?